# An Early Exploratory Clinical Study of GC012F Injection in the Treatment of Refractory Generalized Myasthenia Gravis

> **NCT06759948** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Chongbo Zhao** · enrollment: 18 (estimated)

## Conditions studied

- Generalized Myasthenia Gravis (gMG)

## Interventions

- **DRUG:** GC012F injection

## Key facts

- **NCT ID:** NCT06759948
- **Lead sponsor:** Chongbo Zhao
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-02-15
- **Primary completion:** 2027-02-13
- **Final completion:** 2027-09-10
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2025-01-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06759948

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06759948, "An Early Exploratory Clinical Study of GC012F Injection in the Treatment of Refractory Generalized Myasthenia Gravis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06759948. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*